课题基金 / 基金详情

TAI CHI CHIH: COMPLEMENTARY USE TO ACHIEVE REMISSION IN GERIATRIC DEPRESSION

TAI CHI CHIH: COMPLEMENTARY USE TO ACHIEVE REMISSION IN GERIATRIC DEPRESSION
太极拳：补充使用以缓解老年抑郁症
批准号：
8167114
负责人：
Helen Lavretsky
金额：
$9.82万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-12-01 至 2010-11-30
来源：
https://reporter.nih.gov/project-details/8167114
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseDisease remissionElderlyEscitalopramFundingGrantInstitutionMajor Depressive DisorderPartial RemissionRandomized Controlled Clinical TrialsResearchResearch PersonnelResourcesSourceTai JiUnited States National Institutes of Healthdepressive symptomsgeriatric depression

项目摘要

项目成果

Helen Lavretsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. In a randomized controlled clinical trial, we will determine the complementary effects of 8 weeks of TCC vs. HE on depressive symptoms in older adults with major depression who have completed 8 weeks of treatment with 10 mg/day of escitalopram and have achieved only partial remission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Remote Tai Chi for Knee Osteoarthritis: an Embedded Pragmatic Trial
  • 批准号：
    10649920
  • 项目类别：
  • 资助金额：
    $91.17万
  • 财政年份：
    2023
  • 负责人：
    Helen Lavretsky
  • 依托单位：
    TUFTS MEDICAL CENTER
EFFECTS OF VULNERABILITY AND RESILIENCY ON BRAIN HEALTH DURING THE MID-TO-LATE-LIFE TRANSITION
  • 批准号：
    10673904
  • 项目类别：
  • 资助金额：
    $23.22万
  • 财政年份：
    2021
  • 负责人：
    Helen Lavretsky
  • 依托单位：
    WASHINGTON UNIVERSITY
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression
海外基金